Your browser doesn't support javascript.
loading
Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang, Wenhui; Wang, Tiejun; Liu, Zi; He, Jianli; Sun, Xiaoge; Zhong, Wei; Zhao, Fengjv; Li, Xiaomei; Li, Sha; Zhu, Hong; Ma, Zhanshu; Hu, Ke; Zhang, Fuquan; Hou, Xiaorong; Wei, Lichun; Zou, Lijuan.
Afiliação
  • Wang W; Department of Radiation Oncology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, People's Republic of China.
  • Wang T; Department of Radiation Oncology, The second hospital Affiliated by Jilin University, Changchun, People's Republic of China.
  • Liu Z; Department of Radiation Oncology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
  • He J; Department of Radiation Oncology, The General Hospital of Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China.
  • Sun X; Department of Radiation Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, People's Republic of China.
  • Zhong W; Gynaecological Oncology Radiotherapy, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.
  • Zhao F; Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou, Gansu, People's Republic of China.
  • Li X; Department of Radiation Oncology, Peking University First Hospital, Beijing, People's Republic of China.
  • Li S; Department of Radiation Oncology, The 940th Hospital of Joint Logistics Support force of Chinesc People's Liberation Army, Lanzhou, Gansu, People's Republic of China.
  • Zhu H; Department of Radiation Oncology, Xiangya Hospital Central South University, Changsha, Hunan, People's Republic of China.
  • Ma Z; Department of Radiation Oncology, Affiliated Hospital of Chi feng University, Chifeng, Inner Mongolia, People's Republic of China.
  • Hu K; Department of Radiation Oncology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, People's Republic of China.
  • Zhang F; Department of Radiation Oncology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, People's Republic of China.
  • Hou X; Department of Radiation Oncology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, People's Republic of China. hxr_pumch@163.com.
  • Wei L; Department of Radiation Oncology, Xijing Hospital, Air Force Medical University of PLA (the Fourth Military Medical University), Xi'an, People's Republic of China. weilichun@fmmu.edu.cn.
  • Zou L; Department of Radiation Oncology, The Second Hospital of Dalian Medical University, Dalian, People's Republic of China. suxindai@163.com.
BMC Cancer ; 22(1): 266, 2022 Mar 14.
Article em En | MEDLINE | ID: mdl-35287626
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article